Haase VH, Chertow GM, Block GA, et al. Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents. Nephrol Dial Transplant. 2018 Apr. E-pub.
Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB. Variability in Hemoglobin Levels in Hemodialysis Patients in the Current Era: A Retrospective Cohort Study. Clinical Nephrology. 2017 Nov; 88:254-265.
Martin ER, Smith MT, Maroni BJ, et al. Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease. Am J Nephrol. 2017 Mar;45(5):380-388.
Vadadustat is an investigational drug and has not yet been approved by the US Food and Drug Administration (FDA) or any regulatory authority.